RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 107 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,000 | -72.7% | 213 | -60.4% | 0.00% | -50.0% |
| Q2 2021 | $11,000 | 0.0% | 538 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $11,000 | -50.0% | 538 | -27.0% | 0.00% | -60.0% |
| Q4 2020 | $22,000 | +22.2% | 737 | -11.4% | 0.01% | 0.0% |
| Q3 2020 | $18,000 | -5.3% | 832 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $19,000 | +46.2% | 832 | 0.0% | 0.01% | +20.0% |
| Q1 2020 | $13,000 | -23.5% | 832 | +9.2% | 0.01% | +25.0% |
| Q4 2019 | $17,000 | +1600.0% | 762 | +1365.4% | 0.00% | – |
| Q3 2019 | $1,000 | -91.7% | 52 | -90.8% | 0.00% | -100.0% |
| Q2 2019 | $12,000 | – | 563 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $11,875,000 | 2.75% |
| RA Capital Management | 4,871,067 | $63,616,000 | 0.88% |
| NEA Management Company, LLC | 4,912,306 | $64,155,000 | 0.76% |
| Samsara BioCapital, LLC | 300,293 | $3,922,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,989,625 | $25,985,000 | 0.51% |
| Baker Brothers Advisors | 3,863,239 | $50,454,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 31,000 | $405,000 | 0.21% |
| Rock Springs Capital Management LP | 612,180 | $7,995,000 | 0.17% |
| GILDER GAGNON HOWE & CO LLC | 1,496,424 | $19,543,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,011,053 | $39,324,000 | 0.08% |